Benzinga notes shares of Pharmasset (VRUS -1.4%) are trading a little funky this week...

|By:, SA News Editor

Benzinga notes shares of Pharmasset (VRUS -1.4%) are trading a little funky this week considering the strong market rally and its blockbuster sale to Gilead Sciences (GILD -0.4%). Despite a pickup in chatter that the deal is in jeopardy - a check with analysts covering GILD say the merger is still a "go."